Metraipolis › archive › dc_06441d536fda
Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial — Europe PMC PMID:41871187
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41871187
- DOI
- 10.1155/jdr/2960736
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T03:34:13.629Z
- SHA-256 of the archived text
6b8fe6147aae274435d144a6e2a8699729feb3cf4c3a2e2b47f7c18707805cec- Stable URL of this page
https://metraipolis.com/documento/dc_06441d536fda
How to cite
Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial — Europe PMC PMID:41871187 — Europe PMC (en), https://europepmc.org/article/MED/41871187 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_06441d536fda (Metraipolis archive dc_06441d536fda, sha256 6b8fe6147aae274435d144a6e2a8699729feb3cf4c3a2e2b47f7c18707805cec)
BibTeX
@misc{dc06441d536fda,
title = {Long-Term Safety and Efficacy of Crisugabalin for Diabetic Peripheral Neuropathic Pain: A 52-Week, Multicenter, Single-Arm Trial — Europe PMC PMID:41871187},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41871187},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_06441d536fda; sha256 6b8fe6147aae274435d144a6e2a8699729feb3cf4c3a2e2b47f7c18707805cec},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41871187. Agents can read the archived copy with the MCP tool read_document.